SCHEMBL7147291

SCHEMBL7147291

O=C1CC(c2cccc(-n3ccnc3)c2)=Nc2cc(O)c(-c3ccccc3F)cc2N1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 1.00
GRM2 Q14416 4/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139904 0.89 CYP3A4 (0.80) CYP3A4GRM2
SCHEMBL7138147 0.89 CYP3A4 (0.79) CYP3A4GRM2
SCHEMBL5869045 0.89 CYP3A4 (1.00) CYP3A4GRM2
SCHEMBL7145791 0.87 CYP3A4 (0.77) CYP3A4GRM2
SCHEMBL6165474 0.86 CYP3A4 (0.76) CYP3A4GRM2
SCHEMBL7140734 0.84 CYP3A4 (0.79) CYP3A4
SCHEMBL7143442 0.84 CYP3A4 (0.72) CYP3A4GRM2
SCHEMBL7141738 0.83 CYP3A4 (0.71) CYP3A4
SCHEMBL5869307 0.83 CYP3A4 (0.77) CYP3A4GRM2
SCHEMBL7139601 0.82 CYP3A4 (0.70) CYP3A4GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224174-B1 BENZODIAZEPINE DERIVATIVES AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS HOFFMANN LA ROCHE (CH) 2003-09-17 EP disclosed
US-6407094-B1 4-5-DIDEHYDRO-1,5-BENZODIAZEPIN-2-ONE DERIVATIVES; PSYCHOLOGICAL, NERVOUS SYSTEM, AND BRAIN DISORDERS; COGNITION ACTIVATORS; ALZHEIMER*S DISEASE, SCHIZOPHRENIA HOFFMANN-LA ROCHE INC. 2002-06-18 US disclosed